Interestingly, inhibiting Gβγ signaling largely blocks tumor formation in tibial and femurs but has little effet in the mandible, suggesting GPCR or Gβγ signaling affects bone metastasis differently at different metastasis sites. Here, CFB is linked to neoplasm.